Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $7.4 million.

  • Artiva Biotherapeutics' Non-cash Items rose 59511.05% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 59511.05%. This contributed to the annual value of $1.1 million for FY2024, which is 43064.07% up from last year.
  • According to the latest figures from Q3 2025, Artiva Biotherapeutics' Non-cash Items is $7.4 million, which was up 59511.05% from $7.9 million recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Non-cash Items ranged from a high of $9.4 million in Q1 2025 and a low of $214000.0 during Q4 2023
  • Over the past 3 years, Artiva Biotherapeutics' median Non-cash Items value was $4.3 million (recorded in 2024), while the average stood at $4.5 million.
  • As far as peak fluctuations go, Artiva Biotherapeutics' Non-cash Items surged by 43064.07% in 2024, and later skyrocketed by 59511.05% in 2025.
  • Quarter analysis of 3 years shows Artiva Biotherapeutics' Non-cash Items stood at $214000.0 in 2023, then surged by 430.64% to $1.1 million in 2024, then soared by 551.65% to $7.4 million in 2025.
  • Its Non-cash Items was $7.4 million in Q3 2025, compared to $7.9 million in Q2 2025 and $9.4 million in Q1 2025.